Position in KRYS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$16,700,991
+$6,183,493 QoQ
Shares Held
44,935
+10.4% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#62
of 419 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. KRYS ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,173,152 | $1,079,469,792 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,682,932 | $206,501,997 | |
| 3 | INCY |
Incyte Corp
|
1,480,342 | $167,811,569 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
686,719 | $165,478,677 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
253,764 | $80,212,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
126,343 | $78,779,914 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
172,842 | $52,030,627 | |
| 8 | BNTX |
BioNTech SE
|
539,787 | $50,227,180 |
All Filings in KRYS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,700,991 | 44,935 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $10,517,498 | 40,715 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,523,694 | 26,461 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,676,668 | 54,816 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $11,013,706 | 80,123 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,128,544 | 72,815 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $12,740,844 | 81,328 | Shares | Other | 2025-02-06 | |
| 2024-09-30 | $17,890,818 | 98,285 | Shares | Other | 2024-11-05 | |
| 2024-06-30 | $26,419,368 | 143,865 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $23,988,522 | 134,820 | Shares | Other | 2024-05-03 | |
| 2023-12-31 | $21,447,367 | 172,879 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $24,300,492 | 209,487 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $23,132,378 | 197,039 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $16,983,127 | 212,130 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $26,881,801 | 339,331 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $21,160,850 | 303,599 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,795,669 | 27,348 | Shares | Sole | 2022-08-01 | |
| 2021-12-31 | $200,336 | 2,864 | Shares | Sole | 2022-02-07 | |
| 2021-03-31 | $213,863 | 2,776 | Shares | Sole | 2021-05-04 | |
| 2020-09-30 | $22,564,398 | 524,144 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $11,518,777 | 278,097 | Shares | Other | 2020-08-07 | |
| 2020-03-31 | $68,708 | 1,589 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||